Autor: "Shalekenov, Sanzhar" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Draft genome sequence of a Fusobacterium nucleatum strain isolated from a patient in Kazakhstan with colorectal cancer.
Autorzy:: Kulmambetova G; Genomic Laboratory, National Center for Biotechnology , Astana, Kazakhstan.
Utupov T; Genomic Laboratory, National Center for Biotechnology , Astana, Kazakhstan.
Kurentay B; Genomic Laboratory, National Center for Biotechnology , Astana, Kazakhstan.
Auganova D; Genomic Laboratory, National Center for Biotechnology , Astana, Kazakhstan.
Tarlykov P; Genomic Laboratory, National Center for Biotechnology , Astana, Kazakhstan.
Shevtsov A; Genomic Laboratory, National Center for Biotechnology , Astana, Kazakhstan.
Daniyarov A; National Laboratory Astana, Nazarbayev University , Astana, Kazakhstan.
Khamzina S; Multidisciplinary Surgery Center, National Research Oncology Center , Astana, Kazakhstan.
Mamlin M; Multidisciplinary Surgery Center, National Research Oncology Center , Astana, Kazakhstan.
Kozhakhmetov A; Department of Surgery, Nazarbayev University School of Medicine , Astana, Kazakhstan.
Shalekenov S; Multidisciplinary Surgery Center, National Research Oncology Center , Astana, Kazakhstan.
Źródło:: Microbiology resource announcements [Microbiol Resour Announc] 2023 Sep 15, pp. e0036723. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:: Journal Article

Czasopismo naukowe

Zmień widok

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer.
Autorzy:: Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Shalekenov S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Aziz A; Department of Urology, University of Hamburg, Hamburg, Germany.
van Rhijn BWG; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Lausenmeyer E; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Schäfer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Denzinger S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Giedl C; Institute of Pathology, University of Regensburg, Regensburg, Germany.
Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Hartmann A; Institute of Pathology, University of Erlangen-Nuremberg, Erlangen, Germany.
Evert M; Institute of Pathology, University of Regensburg, Regensburg, Germany.
Otto W; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Źródło:: Bladder cancer (Amsterdam, Netherlands) [Bladder Cancer] 2017 Jul 27; Vol. 3 (3), pp. 173-180. Date of Electronic Publication: 2017 Jul 27.
Typ publikacji:: Journal Article

Czasopismo naukowe

Zmień widok

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.
Autorzy:: Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany. .
Gierth M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.
Shalekenov S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.
Aziz A; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.; Department of Urology, University of Hamburg, Hamburg, Germany.
Schäfer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.
Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.
Denzinger S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.
Hofstädter F; Institute of Pathology, University of Regensburg, Regensburg, Germany.
Giedl C; Institute of Pathology, University of Regensburg, Regensburg, Germany.
Otto W; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.
Źródło:: World journal of urology [World J Urol] 2016 May; Vol. 34 (5), pp. 709-16. Date of Electronic Publication: 2015 Sep 22.
Typ publikacji:: Journal Article
MeSH Terms:: Epithelial-Mesenchymal Transition*
Cadherins/*analysis
Carcinoma, Transitional Cell/*chemistry
Carcinoma, Transitional Cell/*pathology
Inhibitor of Apoptosis Proteins/*analysis
Urinary Bladder Neoplasms/*chemistry
Urinary Bladder Neoplasms/*pathology
Aged ; Aged, 80 and over ; Antigens, CD ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Survivin

Czasopismo naukowe

Zmień widok

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Shalekenov, Sanzhar"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język